- Home
- IVA vs OTLY Comparison
IVA vs OTLY Comparison
Compare IVA & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- OTLY
- Stock Information
- Founded
- IVA 2011
- OTLY 1994
- Country
- IVA France
- OTLY Sweden
- Employees
- IVA N/A
- OTLY N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- OTLY Packaged Foods
- Sector
- IVA Health Care
- OTLY Consumer Staples
- Exchange
- IVA Nasdaq
- OTLY Nasdaq
- Market Cap
- IVA 359.6M
- OTLY 303.5M
- IPO Year
- IVA 2020
- OTLY 2021
- Fundamental
- Price
- IVA $3.09
- OTLY $12.08
- Analyst Decision
- IVA Strong Buy
- OTLY Buy
- Analyst Count
- IVA 4
- OTLY 5
- Target Price
- IVA $10.50
- OTLY $18.40
- AVG Volume (30 Days)
- IVA 29.4K
- OTLY 113.1K
- Earning Date
- IVA 03-26-2025
- OTLY 07-23-2025
- Dividend Yield
- IVA N/A
- OTLY N/A
- EPS Growth
- IVA N/A
- OTLY N/A
- EPS
- IVA N/A
- OTLY N/A
- Revenue
- IVA $14,591,573.00
- OTLY $822,041,000.00
- Revenue This Year
- IVA $15.38
- OTLY $4.31
- Revenue Next Year
- IVA $24.22
- OTLY $5.01
- P/E Ratio
- IVA N/A
- OTLY N/A
- Revenue Growth
- IVA N/A
- OTLY 4.47
- 52 Week Low
- IVA $1.53
- OTLY $6.00
- 52 Week High
- IVA $4.05
- OTLY $23.40
- Technical
- Relative Strength Index (RSI)
- IVA 41.87
- OTLY 53.37
- Support Level
- IVA $3.00
- OTLY $11.55
- Resistance Level
- IVA $3.40
- OTLY $13.26
- Average True Range (ATR)
- IVA 0.20
- OTLY 0.63
- MACD
- IVA -0.04
- OTLY -0.15
- Stochastic Oscillator
- IVA 12.28
- OTLY 28.49
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.